Clinical Trials Browser

Phase 1/2 × palbociclib × Lymphoid × Clear all

NCT02310243 2019-04-16

Study of Palbociclib in MLL-rearranged Acute Leukemias

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma